Comparison of Miller's Blade and Airtraq Laryngoscope in Children
Launched by GOVERNMENT MEDICAL COLLEGE, HALDWANI · Apr 21, 2015
Trial Information
Current as of August 24, 2025
Completed
Keywords
ClinConnect Summary
After approval from the institutional Ethical Committee, 60 patients were studied. A randomised prospective study was planned to compare size 1 Airtraq (Prodol Meditec S.A., Vizcaya, Spain) with Miller blade of same size.
The children included in the study were 2-10 years of age, American Society of Anesthesiologists (ASA) physical status I-II and posted for elective surgeries requiring tracheal intubation. The following were excluded from the study: (i) patients with upper respiratory tract symptoms, (ii) those at risk of gastroesophageal regurgitation and (iii) those with airway-related ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. American Society of Anesthesiologists physical status I-II,
- • 2. elective surgeries requiring tracheal intubation
- Exclusion Criteria:
- • 1. patients with upper respiratory tract symptoms,
- • 2. those at risk of gastroesophageal regurgitation and
- • 3. those with airway-related conditions such a trismus, limited mouth opening, trauma or mass.
About Government Medical College, Haldwani
Government Medical College, Haldwani, is a leading educational institution dedicated to advancing medical research and healthcare delivery. As a clinical trial sponsor, the college fosters innovation in medical science through rigorous research initiatives aimed at improving patient outcomes and public health. With a commitment to ethical standards and regulatory compliance, the institution collaborates with various stakeholders to conduct trials that address pressing health challenges. Its multidisciplinary approach and focus on evidence-based practices position Government Medical College, Haldwani, as a pivotal contributor to the medical research landscape in India.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Shahin N Jamil, M.D.
Study Director
J.N.Medical College, Aligarh Muslim University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials